Nutex Health Q2 2023 net loss $3.5M, revenue $58.9M; plans 1-2 more hospitals in 2023

Nutex Health Inc.

2023-Q2 EPS reported -$0.01 revenue$115,253,871

Net revenue $58.9M in Q2 2023, essentially flat vs $58.0M in Q2 2022.
Net loss attributable to Nutex Health $3.5M vs $19.3M loss in Q2 2022; Adjusted EBITDA $4.0M.
Cash $32.8M; $100M Lincoln Park investment facility unused.
Opened 4 micro-hospitals in 2023; expects 1-2 more in 2023 and 14 by end of 2025.
Closed 3 unprofitable facilities (Texas); paid back $3.75M to Yorkville; $7.7M outstanding.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Nutex Health Inc. reported second quarter 2023 results: revenue $58.9 million, net income $3.5 million net loss.

Period: second quarter 2023
Revenue: $58.9 million
Net income: $3.5 million net loss
Result: reported results

Exact text from the filing

NUTEX HEALTH reports Second quarter 2023 financial results ● NET revenue of $58.9 million

View on SEC.gov

Browse all earnings releases →

Nutex Health Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-014214

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.